Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Joel M. Gelfand, MD, MSCE, FAAD
Guest: Michael S. Garshick, MD
Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining Dr. Mary Cheeley to discuss the connection between the skin and the heart are Drs. Joel Gelfand and Michael Garshick. Dr. Gelfand is a dermatologist at the University of Pennsylvania and the Director of the Psoriasis and Phototherapy Treatment Center and the Center for Clinical Sciences in Dermatology. Dr. Garshick is a cardiologist and the Director of the Cardio-Rheumatology Program at NYU Langone Health, as well as an Assistant Professor of Medicine and Dermatology at NYU Grossman School of Medicine.
--------
--------
Comparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Joel M. Gelfand, MD, MSCE, FAAD
Guest: Valerie Harrison, PhD
Home-based narrowband UVB phototherapy may offer a more accessible and effective option for managing psoriasis, as shown by the results of a recent study. With benefits like improved adherence, lower costs, and greater accessibility, this approach offers a compelling alternative for patients managing chronic disease. Explore the implications of this research and how it could shape future clinical practice with Dr. Joel Gelfand and Valerie Harrison. Dr. Gelfand is the Director of the Psoriasis and Phototherapy Treatment Center and the Center for Clinical Sciences in Dermatology at the University of Pennsylvania, as well as the lead investigator of the LITE study. Valerie Harrison is a study participant and a member of the National Psoriasis Foundation’s Board of Directors.
--------
--------
Examining Psoriasis Prevalence: Diagnostic Differences Across Demographics
Guest: Joe K. Tung, MD, MBA
Psoriasis affects nearly eight million adults in the US, but its impact isn’t felt equally; significant disparities in diagnosis exist across race, ethnicity, and socioeconomic status. Join Dr. Joe Tung as he discusses his recent analysis of data from the National Health Interview Survey, in which he explored the most affected patient populations, the potential for underdiagnosis, and the broader ties between psoriasis, metabolic health, and life satisfaction. Dr. Tung is a board-certified dermatologist currently serving as the Medical Director of UPMC Falk Dermatology, Director of the Clinical Trials Unit, and Associate Director of the Dermatology Residency Program.
--------
--------
Looking Beyond the Skin: The Far-Reaching Impacts of Psoriasis
Guest: Philip J. Mease, MD
Psoriasis is more than just a skin condition—it can significantly impact a patient’s relationships, daily functioning, and overall quality of life. Tune in to hear Dr. Philip J. Mease discuss the multidimensional nature of psoriasis and the importance of a holistic approach to care. Dr. Mease is the Director of Rheumatology Research at Providence Swedish Medical Center and Clinical Professor at the University of Washington.
--------
--------
Future Directions in Psoriasis Treatment: Innovations and Implications
Guest: Andrew Blauvelt, MD, MBA
From novel oral therapies to advancements in biologic injections, the treatment landscape for psoriasis is rapidly evolving. Here to share his insights on how these new treatment strategies could improve efficacy, reduce safety concerns, and even make once-yearly biologic dosing a reality is Dr. Andrew Blauvelt. Dr. Blauvelt is a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.
Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.
New Zealand